Doctors found to lack trust in drug company studies
Doctors are less likely to trust research studies performed with funding from corporate interests such as pharmaceutical companies, according to a new study. The report, published this week in the New England Journal of Medicine, reveals a long-suspected bias against such research among physicians. It also demonstrates the price companies have paid for public violations of trust, including examples of data manipulation and misrepresentation of study results. Within each category, a doctor's trust in the results was heavily influenced by the source of funding: They were only half as willing to prescribe drugs studied in industry-funded trials as compared with NIH-funded studies.
- ICD-10 Delay Alters Provider, Vendor Prep
- Providers Lag as Consumers Set Agenda
- Payment Reform Naysayers 'Better Wake Up'
- Crisis Spurs Healthcare Payment Reform in Arkansas
- HIT Leaders Want Flexibility, Transparency from Next HHS Chief
- As Hospitalist Patient Loads Rise, So Do Hospital Costs
- Esther Dyson Launches Population Health Challenge
- Advance Directives: Let's Make a Law
- Reduce Readmissions by Activating Patients to Do 'Self-Care'
- Hire Care Coordinators Strategically